Publication:
2018 consensus statement by the Spanish Society of Pathology and the Spanish Society of Medical Oncology on the diagnosis and treatment of cancer of unknown primary.

dc.contributor.authorLosa, F
dc.contributor.authorIglesias, L
dc.contributor.authorPané, M
dc.contributor.authorSanz, J
dc.contributor.authorNieto, B
dc.contributor.authorFusté, V
dc.contributor.authorde la Cruz-Merino, L
dc.contributor.authorConcha, Á
dc.contributor.authorBalañá, C
dc.contributor.authorMatías-Guiu, X
dc.date.accessioned2023-01-25T10:09:55Z
dc.date.available2023-01-25T10:09:55Z
dc.date.issued2018-05-28
dc.description.abstractCancer of unknown primary (CUP) is defined as a heterogeneous group of tumours that present with metastasis, and in which attempts to identify the original site have failed. They differ from other primary tumours in their biological features and how they spread, which means that they can be considered a separate entity. There are several hypotheses regarding their origin, but the most plausible explanation for their aggressiveness and chemoresistance seems to involve chromosomal instability. Depending on the type of study done, CUP can account for 2-9% of all cancer patients, mostly 60-75 years old. This article reviews the main clinical, pathological, and molecular studies conducted to analyse and determine the origin of CUP. The main strategies for patient management and treatment, by both clinicians and pathologists, are also addressed.
dc.identifier.doi10.1007/s12094-018-1899-z
dc.identifier.essn1699-3055
dc.identifier.pmcPMC6182632
dc.identifier.pmid29808414
dc.identifier.pubmedURLhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6182632/pdf
dc.identifier.unpaywallURLhttps://link.springer.com/content/pdf/10.1007/s12094-018-1899-z.pdf
dc.identifier.urihttp://hdl.handle.net/10668/12514
dc.issue.number11
dc.journal.titleClinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico
dc.journal.titleabbreviationClin Transl Oncol
dc.language.isoen
dc.organizationHospital Universitario Virgen Macarena
dc.page.number1361-1372
dc.pubmedtypeJournal Article
dc.pubmedtypePractice Guideline
dc.pubmedtypeReview
dc.rightsAttribution 4.0 International
dc.rights.accessRightsopen access
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.subjectBiopsy
dc.subjectCancer of unknown primary
dc.subjectChemotherapy
dc.subjectDiagnosis
dc.subjectHistopathology
dc.subjectImmunohistochemistry
dc.subjectMolecular pathology
dc.subjectPrognosis
dc.subject.meshAged
dc.subject.meshConsensus
dc.subject.meshHumans
dc.subject.meshMedical Oncology
dc.subject.meshMiddle Aged
dc.subject.meshNeoplasms, Unknown Primary
dc.subject.meshPathology, Clinical
dc.subject.meshSocieties, Medical
dc.subject.meshSpain
dc.title2018 consensus statement by the Spanish Society of Pathology and the Spanish Society of Medical Oncology on the diagnosis and treatment of cancer of unknown primary.
dc.typeresearch article
dc.type.hasVersionVoR
dc.volume.number20
dspace.entity.typePublication

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
PMC6182632.pdf
Size:
1.13 MB
Format:
Adobe Portable Document Format